Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.

Oncogene
G L PowersE T Alarid

Abstract

Estrogen receptor-alpha (ERalpha) is a major therapeutic target of hormonal therapies in breast cancer, and its expression in tumors is predictive of clinical response. Protein levels of ERalpha are tightly controlled by the 26S proteasome; yet, how the clinical proteasome inhibitor, bortezomib, affects ERalpha regulation has not been studied. Bortezomib selectively inhibits the chymotrypsin-like activity of the proteasome. Unlike other laboratory proteasome inhibitors, bortezomib failed to stabilize ERalpha protein at a dose exceeding 90% inhibition of the chymotrypsin-like activity. Unexpectedly, however, chronic bortezomib exposure caused a reduction of ERalpha levels in multiple ER+ breast cancer cell lines. This response can be explained by the fact that bortezomib induced a dramatic decrease in ERalpha mRNA because of direct transcriptional inhibition and loss of RNA polymerase II recruitment on the ERalpha gene promoter. Bortezomib treatment resulted in promoter-specific changes in estrogen-induced gene transcription that related with occupancy of ERalpha and RNA polymerase II (PolII) on endogenous promoters. In addition, bortezomib inhibited estrogen-dependent growth in soft agar. These results reveal a novel link betwe...Continue Reading

References

Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A KumatoriA Ichihara
Jan 1, 1987·Journal of Steroid Biochemistry·G FabrisI Nenci
Aug 14, 1981·Biochemical and Biophysical Research Communications·M Orlowski, S Wilk
Jan 1, 1993·Breast Cancer Research and Treatment·M G Parker
Oct 6, 1997·The Journal of Biological Chemistry·W HeinemeyerD H Wolf
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·Z NawazB W O'Malley
Apr 27, 1999·FEBS Letters·A El Khissiin, G Leclercq
Dec 14, 1999·The American Journal of Pathology·B S ShokerJ P Sloane
Dec 4, 2001·Molecular Endocrinology·M KosF Gannon
Feb 13, 2002·The American Journal of Pathology·Abeer M ShaabanChristopher S Foster
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 5, 2003·Annals of Surgery·Maurizio BossolaFrancesco Maria Baccino
Jul 31, 2004·Molecular Endocrinology·Meiyun FanKenneth P Nephew
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manisha H ShahMichael Grever
Jun 21, 2005·Molecular and Cellular Biology·Christopher C ValleyElaine T Alarid
Sep 24, 2005·Molecular Endocrinology·Amy M FowlerElaine T Alarid
Jan 13, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C H YangM Cristofanilli
Jan 18, 2006·Annual Review of Medicine·Paul G RichardsonKenneth C Anderson
Jan 21, 2006·Molecular Endocrinology·Elaine T Alarid
Mar 1, 2006·BMC Bioinformatics·Joshua S YuanC Neal Stewart
Mar 21, 2006·Molecular Cancer Therapeutics·Jordi Codony-ServatJoan Albanell
Jan 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan S CoatesAron Goldhirsch
Mar 30, 2007·Molecular Pharmacology·Corina MarxChristopher C Benz
Jun 27, 2007·The American Journal of Pathology·Sangjun LeeD Craig Allred
Sep 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yuxin FengSohaib A Khan
Sep 11, 2007·Molecular and Cellular Endocrinology·David G DeNardoPowel H Brown
Nov 3, 2007·Cancer Research·Joshua Chuck HarrellKathryn B Horwitz

❮ Previous
Next ❯

Citations

Nov 9, 2011·Molecular and Cellular Biology·Prashant RajbhandariElaine T Alarid
Feb 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuki IshiiDoris Germain
Aug 24, 2012·Epigenetics & Chromatin·Tanja PrenzelSteven A Johnsen
Dec 23, 2014·International Journal of Cancer. Journal International Du Cancer·Sonja ThalerJonathan P Sleeman
Nov 1, 2011·Biochimica Et Biophysica Acta·Sarah Frankland-Searby, Sukesh R Bhaumik
Apr 5, 2011·Biochemical and Biophysical Research Communications·Kwanghee RyuYoungjoo Lee
May 7, 2015·Journal of Molecular Endocrinology·Kyle T HelzerElaine T Alarid
Mar 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ioannis A Voutsadakis
Jan 29, 2020·Experimental Biology and Medicine·Pamella Ramona Moraes de SouzaFernanda Marciano Consolim Colombo
Apr 1, 2020·Biomolecules·Irina V KondakovaNatalia P Sharova
Nov 9, 2017·Oncotarget·Teru HideshimaKenneth C Anderson
Jun 28, 2020·Hormones & Cancer·David K LungElaine T Alarid
Nov 29, 2012·Molecular Biology Reports·Ioannis A Voutsadakis
Sep 17, 2020·Cells·Sarah A JeffreysTherese M Becker
Sep 12, 2012·Molecular Cancer Research : MCR·Marie MaynadierMarcel Garcia

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
PCR
immunoprecipitation
enzyme assay

Software Mentioned

MStat
Graphpad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.